From the Canadian Press:
Two years ago, Scientists had high hopes for new pills that would help people quit smoking, lose weight and maybe kick other tough addictions like alcohol and cocaine.
The pills worked in a novel way, by blocking pleasure centres in the brain that provide the feel-good response from smoking or eating. Now it seems the drugs may block pleasure too well, possibly raising the risk of depression and suicide.
Margaret Bastian of suburban Rochester, N.Y., was among patients who reported problems with Chantix, a highly touted quit-smoking pill from Pfizer Inc. that has been linked to dozens of reports of suicides and hundreds of suicidal behaviours. The product is sold as Champix in Canada and other countries.
"I started to get severely depressed and just going down into that hole ... the one you can't crawl out of," said Bastian, whose doctor took her off Chantix after she swallowed too many sleeping pills and other medicines one night. ...more
Thursday, April 24, 2008
Risk of depression dims hopes for new anti-addiction pills
Labels:
Acomplia,
Champix,
Chantrix,
depression,
rimonabant,
varenicline
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment